Edition:
United Kingdom

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

1,950.50INR
10:59am BST
Change (% chg)

Rs-52.80 (-2.64%)
Prev Close
Rs2,003.30
Open
Rs2,003.55
Day's High
Rs2,019.45
Day's Low
Rs1,940.00
Volume
7,017
Avg. Vol
15,276
52-wk High
Rs2,397.70
52-wk Low
Rs1,306.05

Latest Key Developments (Source: Significant Developments)

Astrazeneca Pharma Receives Import, Market Permission For Osimertinib Tablet
Thursday, 9 Aug 2018 

Aug 9 (Reuters) - Astrazeneca Pharma India Ltd ::ASTRAZENECA PHARMA INDIA -GOT IMPORT, MARKET PERMISSION IN FORM 45 FROM DRUGS CONTROLLER GENERAL OF INDIA FOR OSIMERTINIB TABLET 40 MG,80 MG.ASTRAZENECA PHARMA INDIA LTD - OSIMERTINIB TABLET INDICATED FOR FIRST-LINE TREATMENT OF CERTAIN NON-SMALL CELL LUNG CANCERS.  Full Article

Astrazeneca Pharma India says FDC Of XIGDUO XR Tablets Expected To Launch In India In Q4
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Astrazeneca Pharma India Ltd ::FDC OF DAPAGLIFLOZIN + METFORMIN HYDROCHLORIDE FILM COATED TABLETS EXPECTED TO LAUNCH IN INDIA IN Q4 2017-18.  Full Article

Astrazeneca Pharma India Sept-qtr profit surges
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Astrazeneca Pharma India Ltd ::Sept quarter profit 273.8 million rupees.Sept quarter revenue from operations 1.64 billion rupees.Profit in sept quarter last year was 8 million rupees as per ind-as; revenue from operations was 1.39 billion rupees.  Full Article

Astrazeneca Pharma India gets marketing approval for combination of therapies for type 2 diabetes‍​
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Astrazeneca Pharma India Ltd ::Gets marketing approval for Xigduo XR, combination of two anti-diabetic therapies for type 2 diabetes‍​.  Full Article

No consensus analysis data available.